ImmunityBio
IBRX
$6.42
Share price
-2.87%
Change (1 day)
118.37%
Change (1 year)
Categories
ImmunityBio (IBRX) - Cash on Hand
Cash on Hand as of March 2024 : $0.17 B
According to ImmunityBio's latest financial reports the company has $0.17 B in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
ImmunityBio - Cash on Hand chart (from 2020 to 2024)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2022-12-31 | $0.10 B | -66.2% |
| 2021-12-31 | $0.31 B | 230.12% |
| 2020-12-31 | $96.06 M |
Cash on Hand for similar companies or competitors
| Company | Cash on Hand | differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | $0.31 B | 85.80% | 🇺🇸 USA |